Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Temsirolimus Does Not Improve Survival in Metastatic Renal Cell Carcinoma

By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results from two randomized controlled trials. “While an...

Reuters Health • The Doctor's Channel Daily Newscast

PET-CT Accurately Identifies Colorectal Metastases with Poor Prognosis

NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease and who are therefore deemed incurable, according to a UK...

Reuters Health • The Doctor's Channel Daily Newscast

Trastuzumab has Moderate Benefit in HER2-Negative Breast Cancer

NEW YORK (Reuters Health) – Although trastuzumab is directed against the HER2 protein, patients with HER2-negative breast cancer may also benefit from adjuvant trastuzumab therapy, researchers report. They say this provides “justification for testing...